Thorne HealthTech company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year




Date of IPO


Market Cap


Stock Price


About Thorne HealthTech

Thorne HealthTech (NASDAQ: THRN) provides nutritional supplements that target a number of health areas including cardiovascular support, immune support, sports performance and more.

Thorne HealthTech Headquarter Location

152 West 57th Street 10th Floor

New York, New York, 10019,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Thorne HealthTech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Thorne HealthTech is included in 4 Expert Collections, including Vitamin & Supplement Startups.


Vitamin & Supplement Startups

648 items


Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.


Health Monitoring & Diagnostics

2,598 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Thorne HealthTech Patents

Thorne HealthTech has filed 4 patents.

The 3 most popular patent topics include:

  • Amino acid metabolism disorders
  • Autosomal recessive disorders
  • Histone deacetylase inhibitors
patents chart

Application Date

Grant Date


Related Topics




Autosomal recessive disorders, Rare diseases, Metabolism, Histone deacetylase inhibitors, Amino acid metabolism disorders


Application Date


Grant Date



Related Topics

Autosomal recessive disorders, Rare diseases, Metabolism, Histone deacetylase inhibitors, Amino acid metabolism disorders



Latest Thorne HealthTech News

Thorne HealthTech Achieves Self-Affirmed GRAS Status for Nicotinamide Riboside Malate

Jul 19, 2022

News provided by Share this article Share this article NEW YORK, July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN ), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced that it has achieved self-affirmed GRAS (Generally Recognized as Safe) status for its proprietary nicotinamide riboside malate (NRM) product. Under the Federal Food, Drug and Cosmetic Act, GRAS is a regulatory classification term used to identify a food ingredient that is generally recognized among qualified experts as having been adequately shown to be safe under the conditions of its intended use. Self-affirmed GRAS status requires that an ingredient undergo extensive quality and safety testing, as well as review by an independent outside expert panel. Based on extensive analysis, Thorne's NRM has been established as having a quality, safety, and purity profile equal to or superior to other forms of nicotinamide riboside currently on the market. Thorne's NRM is also NSF Certified for Sport®, with each batch being independently tested by NSF. The NSF Certified for Sport® program provides the highest possible level of safety and testing to ensure products do not contain contaminants, banned substances, or masking agents, and that what is on the label matches what is in the product. Thorne's NRM product suite includes NiaCel®, Collagen Fit, ResveraCel®, and Advanced Nutrients, among other products. "The benefits of nicotinamide riboside are vast, because researchers have found that nicotinamide riboside directly stimulates the production of energy in the body through NAD+, one of the most critical molecules in our bodies," said Thorne HealthTech CEO, Paul Jacobson. "Our proprietary nicotinamide riboside malate has proven to be best-in-class, and its new GRAS status is a major endorsement reinforcing the quality and safety of our product." About Thorne HealthTech Thorne HealthTech is a leader in developing innovative solutions for delivering personalized approaches to health and wellness. As a science-driven health and wellness company that empowers individuals with the support, education, and solutions they need to achieve healthy aging – living healthier longer – Thorne utilizes testing and data to create improved product efficacy and to deliver personalized solutions to consumers, health professionals, and corporations. Predicated on the power of the individual, Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health and wellness over a lifetime. Thorne is the only supplement manufacturer that collaborates with Mayo Clinic on health and wellness research and content, and is trusted by more than four million customers, 45,000+ health-care professionals, thousands of professional athletes, and more than 100 professional sports teams and U.S. National Teams. For more information, visit SOURCE Thorne HealthTech, Inc.

Thorne HealthTech Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Thorne HealthTech Rank

  • When was Thorne HealthTech founded?

    Thorne HealthTech was founded in 1984.

  • Where is Thorne HealthTech's headquarters?

    Thorne HealthTech's headquarters is located at 152 West 57th Street, New York.

  • What is Thorne HealthTech's latest funding round?

    Thorne HealthTech's latest funding round is IPO.

  • Who are the investors of Thorne HealthTech?

    Investors of Thorne HealthTech include Kirin Holdings Company, Mitsui & Co., Tudor Ventures, WestView Capital Partners and Helsinn.

  • Who are Thorne HealthTech's competitors?

    Competitors of Thorne HealthTech include Healthycell.

You May Also Like

MaryRuth Organics Logo
MaryRuth Organics

MaryRuth Organics is a vitamin, minerals, and supplements brand offering organic and vegan nutritional supplements to benefit the entire family, from infants to adults. MaryRuth boasts a large portfolio of liquid, gummy, and chewable products spanning multiple categories, including multivitamins, probiotics, herbal and adaptogen supplements, and more. MaryRuth sells its products online via its own website, as well as on Amazon and in Whole Foods Market.

Healthycell Logo

Healthycell is a developer of a pill-free dietary supplement line designed to deliver nutrients that can be absorbed. It is based in Mount Pleasant, South Carolina.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.